117 related articles for article (PubMed ID: 38214420)
61. Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo.
Li S; Kang P; Zhang W; Jian Z; Zhang Q; Yi X; Guo S; Guo W; Shi Q; Li B; He Y; Song P; Liu L; Li K; Wang G; Gao T; Li C
J Allergy Clin Immunol; 2020 Feb; 145(2):632-645. PubMed ID: 31756352
[TBL] [Abstract][Full Text] [Related]
62. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes.
Lu Y; Tschickardt ME; Schmidt BJ; Blanck G
Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472
[TBL] [Abstract][Full Text] [Related]
63. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
64. NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis.
Xia P; Shao YQ; Yu CC; Xie Y; Zhou ZJ
BMC Immunol; 2022 Aug; 23(1):39. PubMed ID: 35965334
[TBL] [Abstract][Full Text] [Related]
65. Altered Th1 cell differentiation programming by CIITA deficiency.
Patel DR; Kaplan MH; Chang CH
J Immunol; 2004 Nov; 173(9):5501-8. PubMed ID: 15494498
[TBL] [Abstract][Full Text] [Related]
66. T cell expression of CIITA represses Th1 immunity.
Park WS; Bae Y; Chung DH; Choi YL; Kim BK; Sung YC; Choi EY; Park SH; Jung KC
Int Immunol; 2004 Oct; 16(10):1355-64. PubMed ID: 15351782
[TBL] [Abstract][Full Text] [Related]
67. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
68. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
[TBL] [Abstract][Full Text] [Related]
69. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins.
Lee SJ; Qin H; Benveniste EN
Eur J Immunol; 2008 Aug; 38(8):2325-36. PubMed ID: 18601229
[TBL] [Abstract][Full Text] [Related]
70. NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1β/Th1/IFN-γ in acute myeloid leukemia.
Liu Q; Hua M; Zhang C; Wang R; Liu J; Yang X; Han F; Hou M; Ma D
Cancer Lett; 2021 Nov; 520():109-120. PubMed ID: 34237408
[TBL] [Abstract][Full Text] [Related]
71. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
[TBL] [Abstract][Full Text] [Related]
72. [Major histocompatibility complex class II transactivator (CIITA) hammer- head ribozyme transfer inhibits major histocompatibility complex class II (MHC-II) expression in Jukart cells].
Guo R; Zou P; Song YP; Ma J; Lu HZ; Cao YL; Tong YJ
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):925-8. PubMed ID: 14723817
[TBL] [Abstract][Full Text] [Related]
73. FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.
Kasuga Y; Ouda R; Watanabe M; Sun X; Kimura M; Hatakeyama S; Kobayashi KS
Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2218955120. PubMed ID: 37279268
[TBL] [Abstract][Full Text] [Related]
74. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
75. K-562 cells lack MHC class II expression due to an alternatively spliced CIITA transcript with a truncated coding region.
Day NE; Ugai H; Yokoyama KK; Ichiki AT
Leuk Res; 2003 Nov; 27(11):1027-38. PubMed ID: 12859996
[TBL] [Abstract][Full Text] [Related]
76. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
77. The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.
Xu Y; Luchsinger L; Lucey EC; Smith BD
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):898-905. PubMed ID: 20705943
[TBL] [Abstract][Full Text] [Related]
78. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
79. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
80. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
O'Keefe GM; Nguyen VT; Benveniste EN
Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
